Articles with public access mandates - Professor Maarten IJzermanLearn more
Not available anywhere: 1
Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomes
J Zhang, MJ IJzerman, J Oberoi, N Karnchanachari, RJ Bergin, ...
Lung Cancer 166, 27-39, 2022
Mandates: National Health and Medical Research Council, Australia
Available somewhere: 65
Helmet therapy in infants with positional skull deformation: randomised controlled trial
RM van Wijk, LA van Vlimmeren, CGM Groothuis-Oudshoorn, ...
Bmj 348, 2014
Mandates: Netherlands Organisation for Health Research and Development
A review and classification of approaches for dealing with uncertainty in multi-criteria decision analysis for healthcare decisions
H Broekhuizen, CGM Groothuis-Oudshoorn, JA van Til, JM Hummel, ...
Pharmacoeconomics 33, 445-455, 2015
Mandates: Netherlands Organisation for Health Research and Development
Impact of organ-on-a-chip technology on pharmaceutical R&D costs
N Franzen, WH van Harten, VP Retèl, P Loskill, ...
Drug discovery today 24 (9), 1720-1724, 2019
Mandates: European Commission
Randomized controlled trial of surface peroneal nerve stimulation for motor relearning in lower limb hemiparesis
LR Sheffler, PN Taylor, DD Gunzler, JH Buurke, MJ IJzerman, J Chae
Archives of physical medicine and rehabilitation 94 (6), 1007-1014, 2013
Mandates: US National Institutes of Health
Transforming healthcare delivery: integrating dynamic simulation modelling and big data in health economics and outcomes research
DA Marshall, L Burgos-Liz, KS Pasupathy, WV Padula, MJ IJzerman, ...
PharmacoEconomics 34, 115-126, 2016
Mandates: Natural Sciences and Engineering Research Council of Canada
Addressing challenges of economic evaluation in precision medicine using dynamic simulation modeling
DA Marshall, LR Grazziotin, DA Regier, S Wordsworth, J Buchanan, ...
Value in health 23 (5), 566-573, 2020
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Machine learning methods in health economics and outcomes research—the PALISADE checklist: a good practices report of an ISPOR task force
WV Padula, N Kreif, DJ Vanness, B Adamson, JD Rueda, F Felizzi, ...
Value in health 25 (7), 1063-1080, 2022
Mandates: US National Institutes of Health
Implementation of whole-genome and transcriptome sequencing into clinical cancer care
E Cuppen, O Elemento, R Rosenquist, S Nikic, M IJzerman, ID Zaleski, ...
JCO Precision Oncology 6, e2200245, 2022
Mandates: US National Institutes of Health, Natural Sciences and Engineering Research …
How to agree on a CTC: evaluating the consensus in circulating tumor cell scoring
LL Zeune, S de Wit, AMS Berghuis, MJ IJzerman, LWMM Terstappen, ...
Cytometry Part A 93 (12), 1202-1206, 2018
Mandates: European Commission
Consensus statement on circulating biomarkers for advanced prostate cancer
S Sumanasuriya, A Omlin, A Armstrong, G Attard, KN Chi, CL Bevan, ...
European urology oncology 1 (2), 151-159, 2018
Mandates: Prostate Cancer UK
Response to pediatric physical therapy in infants with positional preference and skull deformation
RM van Wijk, M Pelsma, CGM Groothuis-Oudshoorn, MJ IJzerman, ...
Physical therapy 94 (9), 1262-1271, 2014
Mandates: Netherlands Organisation for Health Research and Development
Health economic impact of liquid biopsies in cancer management
MJ IJzerman, AMS Berghuis, JS de Bono, LWMM Terstappen
Expert review of pharmacoeconomics & outcomes research 18 (6), 593-599, 2018
Mandates: Cancer Research UK
An empirical comparison of discrete choice experiment and best-worst scaling to estimate stakeholders’ risk tolerance for hip replacement surgery
JD van Dijk, CGM Groothuis-Oudshoorn, DA Marshall, MJ IJzerman
Value in Health 19 (4), 316-322, 2016
Mandates: Natural Sciences and Engineering Research Council of Canada
Screening for postpartum depression in well-baby care settings: a systematic review
AI van der Zee-van den Berg, MM Boere-Boonekamp, MJ IJzerman, ...
Maternal and child health journal 21, 9-20, 2017
Mandates: Netherlands Organisation for Health Research and Development
Patient preferences for next generation neural prostheses to restore bladder function
PMH Sanders, MJ IJzerman, MJ Roach, KJ Gustafson
Spinal Cord 49 (1), 113-119, 2011
Mandates: US National Institutes of Health
Surface peroneal nerve stimulation in lower limb hemiparesis: effect on quantitative gait parameters
LR Sheffler, PN Taylor, SN Bailey, DD Gunzler, JH Buurke, MJ IJzerman, ...
American journal of physical medicine & rehabilitation 94 (5), 341-357, 2015
Mandates: US National Institutes of Health
Return-to-work intervention for cancer survivors: budget impact and allocation of costs and returns in the Netherlands and six major EU-countries
JC Mewes, LMG Steuten, IF Groeneveld, AGEM de Boer, ...
BMC cancer 15, 1-10, 2015
Mandates: Dutch Cancer Society
A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours
YJ Kang, S O’Haire, F Franchini, M IJzerman, J Zalcberg, F Macrae, ...
Scientific reports 12 (1), 20495, 2022
Mandates: Medical Research Future Fund, Australia
Involving patients in weighting benefits and harms of treatment in Parkinson's disease
MGM Weernink, JA van Til, JPP van Vugt, KLL Movig, ...
PloS one 11 (8), e0160771, 2016
Mandates: Netherlands Organisation for Health Research and Development
Publication and funding information is determined automatically by a computer program